Literature DB >> 8596574

Autoimmune hepatitis.

E L Krawitt1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8596574     DOI： 10.1056/NEJM199604043341406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

1.  Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis.

Authors:  M Murota; M Nishioka; J Fujita; N Dobashi; F Wu; Y Ohtsuki; S Hojo; J Takahara; S Kuriyama
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Liver enzyme alteration: a guide for clinicians.

Authors:  Edoardo G Giannini; Roberto Testa; Vincenzo Savarino
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

3.  Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.

Authors:  Kiyoshi Migita; Yukio Watanabe; Yuka Jiuchi; Yoko Nakamura; Akira Saito; Michiyasu Yagura; Hideo Morimoto; Masaaki Shimada; Eiji Mita; Taizo Hijioka; Haruhiro Yamashita; Eiichi Takezaki; Toyokichi Muro; Hironori Sakai; Makoto Nakamuta; Seigo Abiru; Koji Yano; Atsumasa Komori; Hiroshi Yatsuhashi; Minoru Nakamura; Hiromi Ishibashi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

4.  Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.

Authors:  R Malekzadeh; S Nasseri-Moghaddam; M J Kaviani; H Taheri; N Kamalian; M Sotoudeh
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

5.  Glutathione-S-Transferase M1 null genotype in autoimmune hepatitis.

Authors:  N K Fukagawa; P Liang; M Li; T Ashikaga; K R Reddy; E L Krawitt
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

6.  Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group.

Authors:  Lok-Beng Koay; Ching-Yih Lin; Sun-Lung Tsai; Chuan Lee; Ching-Nan Lin; Ming-Juen Sheu; Hsing-Tao Kuo; Chi-Shu Sun
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

7.  Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.

Authors:  H Hofer; C Oesterreicher; F Wrba; P Ferenci; E Penner
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

8.  Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.

Authors:  Andreas Geier; Carsten Gartung; Christoph G Dietrich; Hermann E Wasmuth; Patrick Reinartz; Siegfried Matern
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.

Authors:  Bing Zhu; Shao-Li You; Zhi-Hong Wan; Hong-Ling Liu; Yi-Hui Rong; Hong Zang; Shao-Jie Xin
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Gut and oral microbiota in autoimmune liver disease.

Authors:  Kazumichi Abe; Masashi Fujita; Manabu Hayashi; Ken Okai; Atsushi Takahashi; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2019-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.